BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Jan 16, 15:50Prev. Close
92.71
Open Price
92.71
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Par Drugs & Chemicals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 17.92 | 19.52 | 15.08 | 12.70 | 14.73 | |
| Net CashFlow From Operating Activities | 16.16 | 20.25 | 13.38 | 7.62 | 12.09 | |
| Net Cash Used In Investing Activities | -25.24 | -5.84 | -7.34 | -3.02 | 0.05 | |
| Net Cash Used From Financing Activities | 0.00 | 0.00 | 0.00 | -9.55 | 1.65 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -9.08 | 14.41 | 6.04 | -4.96 | 13.78 | |
| Cash And Cash Equivalents Begin of Year | 36.65 | 22.24 | 16.21 | 21.16 | 7.38 | |
| Cash And Cash Equivalents End Of Year | 27.58 | 36.65 | 22.24 | 16.21 | 21.16 |
27.11.2025
Par Drugs Standalone September 2025 Net Sales at Rs 28.66 crore, down 17.31% Y-o-Y
22.08.2025
Par Drugs Standalone June 2025 Net Sales at Rs 26.05 crore, up 15.22% Y-o-Y
12.05.2025
Par Drugs Standalone March 2025 Net Sales at Rs 22.33 crore, down 2.14% Y-o-Y
23.10.2024
Par Drugs Standalone September 2024 Net Sales at Rs 34.66 crore, up 33.88% Y-o-Y
15.03.2018
24.04.2017
24.04.2017
20.04.2017